System and method for ventricular interval smoothing following a premature ventricular contraction

• US 7,894,898 B2
• Filed: 06/15/2006
• Issued: 02/22/2011
• Est. Priority Date: 06/15/2006
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Sweeney, Michael O., Belk, Paul A., Sheldon, Todd J.
• Primary Examiner(s): Manuel; George
• Assistant Examiner(s): Narayanaswamy; Shubatra
• Application Number:
  US11/424,405
• Publication Number:
  US 20070293899A1
• Time in Patent Office: 1,713 Days
• Field of Search: 607/9, 607/14, 607/16
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence

Abstract

An implantable medical device includes cardiac pacing functions. In order to reduce ventricular pacing, various modes are employed that tolerate missed ventricular beats, provide backup pacing and maintain overall AV synchrony. Upon the occurrence of a PVC, A-A timing is modified so that resultant V-V intervals are appropriate and ventricular pacing is avoided.

Claims

1. An implantable medical device (IMD) comprising:

means for sensing cardiac data;

means for identifying premature ventricular contractions (PVC) from the cardiac data;

means for pacing responsive to the means for sensing;

a ventricular pacing protocol (VPP) module for controlling the means for pacing and to prevent ventricular pacing in a given cardiac cycle wherein a ventricular sensed event occurred in a cardiac cycle immediately prior to the given cardiac cycle; and

means for controlling a V-V interval immediately following and initiated by an identified PVC by selectively varying an A-A interval.

2. The IMD of claim 1, wherein the means for controlling the V-V interval preclude ventricular pacing to control the V-V interval.

3. The IMD of claim 1, wherein the means for controlling the V-V interval include means for determining a desired ventricular sense time and calculating an A-A interval to facilitate the desired ventricular sense time.

4. The IMD of claim 3, wherein the desired ventricular sense time results in a PVC to ventricular sense interval (V-V (2)) that is correlated with a ventricular sensed event to PVC interval (V-V(1)).

5. The IMD of claim 4, wherein the correlation is that V-V(2)=V-V(1)+a predetermined constant.

6. The IMD of claim 4, wherein the correlation is that V-V(2)=V-V(1)+(X %*V-V(1)).

7. The IMD of claim 4, further comprising means for determining an AV interval for the V-V(2) interval and the A-A interval is set to an A-AP interval wherein the AP initiates an the AV interval.

8. The IMD of claim 4, further comprising means for generating progressively longer V-V intervals immediately subsequent to V-V(2) until a pre-PVC V-V interval is achieved, wherein the pre-PVC interval is a V-V interval duration occurring in the cardiac cycle prior to that having the PVC.

9. An implantable medical device (IMD) comprising:

a cardiac pacing module;

a ventricular pacing protocol (VPP) module configured to control the pacing module and prevent ventricular pacing in a given cardiac cycle wherein a ventricular sensed event occurred in a cardiac cycle immediately prior to the given cardiac cycle and permit ventricular pacing in the given cardiac cycle if no ventricular event was sensed in the immediately prior cardiac cycle; and

a ventricular interval smoothing module configured to respond to a sensed PVC and alter atrial intervals to create one or more consecutive V-V intervals having a progressively larger duration without providing ventricular pacing.

10. The IMD of claim 9, further comprising a calculation module to calculate a desired ventricular sense time, determine an appropriate A-A interval that results in the desired ventricular sense time and provides the ventricular interval smoothing modules with the A-A interval to alter the atrial interval.

11. A method comprising:

operating a cardiac pacing device according to a ventricular pacing protocol (VPP);

sensing a premature ventricular contraction (PVC) in a first cardiac cycle;

measuring a duration of a first ventricular interval from a ventricular event immediately preceding the PVC to the PVC;

calculating a duration of a second ventricular interval to occur from the PVC to a target ventricular sensed event; and

modifying atrial timing in the first cardiac cycle to effect the second ventricular interval.

12. The method of claim 11, wherein the second ventricular interval occurs without ventricular pacing.

13. The method of claim 11, modifying atrial timing in subsequent consecutive cycles until a resultant V-V interval is substantially equal to a V-V interval prior to the first ventricular interval.

14. The method of claim 13, wherein the modification of atrial timing in subsequent consecutive cycles results in a smoothing of the resultant V-V intervals.

15. The method of claim 11, wherein calculating the duration of the second ventricular interval includes adding a constant to the duration of the first ventricular interval.

16. The method of claim 15, wherein the constant is selected from a table and the table includes constant values for corresponding ventricular intervals.

17. The method of claim 11, wherein calculating the duration of the second ventricular interval includes increasing the first ventricular interval by a predetermined percentage.

18. The method of claim 11, further comprising:

sensing for atrial refractory events; and

adding a predetermined value to the modified atrial timing if an atrial refractory event is sensed.

19. The method of claim 11, further comprising:

setting a first AV interval for delivering a ventricular backup pacing pulse following an A-A interval devoid of a sensed ventricular event according to the VPP;

setting a second AV interval for delivering a ventricular pacing pulse following a truncated A-A interval as modified to effect the second ventricular interval wherein the second AV interval is longer than the first AV interval.

20. The method of claim 11, wherein modifying the atrial timing includes determining an AV interval that would result in the target sensed ventricular event and delivering an atrial pacing pulse at so that the atrial pacing pulse initiated the AV interval.